Better Imaging Today

Welcome to the University of Pittsburgh Department of Radiology. We are one of the nation’s largest and most productive academic radiology departments in the world, with nearly 200 dedicated clinical and research faculty. Our physicians practice in the hospitals and clinics of the UPMC, one of the nation’s outstanding health systems, honored repeatedly by U.S. News & World Report. The research program is currently one of the top funded radiology departments, with over 10 million dollars in total funding. Our residency program is one of the largest programs in the country.

Graduation 2018

The Department of Radiology held a graduation dinner for the graduating residents and fellows on Wednesday, June 6, 2018. The celebration was held at the University Club in Oakland and had over 130 people in attendance. Prior to the event, residents had the opportunity to vote for faculty for several awards.

Click here to see the Award Recipients.

Click here to see Graduation 2018 Photo Album on Google Photo.

Imaging in Urology

Title: Imaging in Urology

Dr. Tublin and Dr. Joel Nelson (Chairman, Department of Urology) and Drs. Borhani, Furlan, Heller and Squires published an image rich review of GU radiology relevant for urology trainees and junior urology faculty.

Imaging in Urology, 1st Edition
https://www.us.elsevierhealth.com/imaging-in-urology-9780323548090.html#panel1


Please click the text book image for detail information.

UPMC Radiologists named in Pittsburgh Magazine’s Best Doctors of 2018

Congratulations to the radiologists: Wendie Berg, Vinod Nanik Chablani, Charles R. Fitz, Carl Fuhrman, Emanuel Kanal, Joan M. Lacomis, James M. Mountz, Paula M. Novelli, William E. Rothfus, Mitchell E. Tublin, Giulio Zuccoli as “Pittsburgh Magazine’s Best Doctors” of 2018.







Lung Density Analysis for Quantification of Emphysema on Chest CT Scans

Low dose CT scans obtained for lung cancer screening are now including a quantification of emphysema using software developed by the Imbio company (based in Minneapolis, MN).

Lung density analysis for emphysema is now FDA approved and has the technology has been validated by multiple studies. The process is fully automatic (data sent from scanner to Imbio software) with results included with CT images within minutes.

Dense Breast Tomosynthesis Ultrasound Screening Trial (DBTUST)

Dense breast tissue, which is common, and normal (seen in about 40% of women screened), can mask detection of breast cancer on mammography. Ultrasound is known to improve invasive cancer detection after standard mammography in women with dense breasts. Tomosynthesis (3D mammography) improves cancer detection compared to standard mammography. It is not known whether ultrasound would still be of benefit or not after tomosynthesis in women with dense breasts. Opened in December 2015, the purpose of this study is to determine the added cancer detection yield (if any) when screening ultrasound is added to 3D mammography in women with dense breasts. Women will undergo three annual rounds of screening. The cost of the screening ultrasound is covered by the study, funded by the National Cancer Institute and the Pennsylvania Breast Cancer Coalition.

RSNA 2017: University of Pittsburgh School of Medicine Department of Radiology

UPMC RSNA Book 2017
UPMC radiology was again a major force at RSNA this year. Faculty and trainees presented 17 scientific papers/posters, compiled 4 educational exhibits, moderated 4 scientific sessions and gave 6 refresher courses. Drs. Zuley and Tublin were appointed to the RSNA Refresher Course Committee as track chairs in breast and ultrasound and Dr. Rath assumed the chairmanship of the RSNA Education Exhibits Award Committee. The midweek alumni reception was spectacular and it was great to hear of the many accomplishments of alumni throughout the US.

F-18 fluciclovine (AxuminTM) PET/CT for prostate cancer biochemical recurrence - available at UPMC Shadyside since September 2017

UPMC Shadyside is the first site in Pittsburgh and southwestern Pennsylvania to offer a new F-18 Positron-Emission-Tomography/Computed-Tomography (PET/CT) scan for prostate cancer patients with biochemical recurrence. The novel PET agent F-18 fluciclovine (AxuminTM) was FDA approved in May 2016 and is useful for detecting low prostate-specific antigen (PSA) soft tissue and bone recurrence. This clinical service is the result of close collaboration between the Departments of Radiology and Radiation Oncology. Patients with F-18 PET/CT positive studies may be eligible for targeted radiotherapy: imaging data acquired can be directly retrieved and incorporated for radiation treatment planning.

Pages

Subscribe to Department of Radiology RSS